Lucid Diagnostics Inc.

About Lucid Diagnostics Inc.

Lucid Diagnostics is focused on empowering clinicians through early detection to prevent esophageal cancer. They aim to revolutionize the detection of esophageal precancer using advanced DNA testing technology, with a mission to make esophageal cancer a disease of the past.

Products & Services

EsoGuard:A groundbreaking DNA test for detecting esophageal precancer, allowing identification during a simple office-based visit without the need for endoscopy.

EsoCheck:A tool or technology associated with precancer detection, specifics not detailed in the content.

Specialties

Esophageal Precancer Detection DNA Testing Next Generation Sequencing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 26900000 MR: - FA: $26.9 million FAN: 26900000	D: 2025-09-11 FD: 2025-09-11	3 investors
2	RT: Public Offering T: - FT: Public Offering	A: 25000000 MR: - FA: approximately $25.0 million FAN: 25000000	D: 2025-09-10 FD: 2025-09-10	3 investors
3	RT: Public Offering T: - FT: Public Offering	A: 16100000 MR: - FA: approximately $16.1 million FAN: 16100000	D: 2025-04-11 FD: 2025-04-11	2 investors
4	RT: Public Offering T: - FT: Public Offering	A: 15000000 MR: - FA: approximately $15 million FAN: 15000000	D: 2025-04-09 FD: 2025-04-09	2 investors
5	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 15300000 MR: - FA: approximately $15.3 million FAN: 15300000	D: 2025-03-05 FD: 2025-03-05	-
6	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 15300000 MR: - FA: 15.3 million FAN: 15300000	D: 2025-03-04 FD: 2025-03-04	-
7	RT: Convertible Debt T: - FT: Convertible Debt	A: 18340000 MR: - FA: $18.34 million FAN: 18340000	D: 2024-12-03 FD: 2024-12-03	1 investors

Public Offering Latest

2025-09-11

$26.9M

3 investors (Pro only)

Public Offering 2025-09-10

$25.0M

Public Offering 2025-04-11

$16.1M

View 6 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tiffany Bae

MSN, APRN, FNP-C

B

Brett Spring

Senior District Manager

J

Jessie Gifford

Senior Director, Product Development & Manufacturing

A

Abhisek Ghosal

Principal Scientist

L

Lisa Bradley

Manager

L

Lishan Aklog

Chairman and Chief Executive Officer

View 27 more team members with Pro

Unlock Full Team Directory

Recent News